Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT05378061 Recruiting - Clinical trials for Post-Traumatic Headache

Hypersensitivity to PACAP-38 in Post-Traumatic Headache

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

The aim is to investigate whether signaling molecule PACAP-38 induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

NCT ID: NCT05377437 Completed - Migraine Clinical Trials

Natural Language Processing for Headache Medicine

Start date: August 28, 2020
Phase: N/A
Study type: Interventional

Headache disorders are diagnosed by clinical history taking and applying the criteria provided within the International Classification of Headache Disorders Third Edition (ICHD-3). To help patients and physicians in making the correct diagnosis, digital technologies based on natural language processing (NLP) approaches may help to identify headache disorders within naturally patient-provided speech. The research aims to develop statistical models through machine-learning NLP applications for the accurate and precise classification of headache disorders with headache expert given ICHD-3 diagnosis as the gold standard. Furthermore, the research also aims to develop statistical models through machine-learning NLP applications for the estimation of impact scores derived from validated headache questionnaires by using texts as input. Patients from the tertiary headache clinic will be recruited to provide oral narrative textual descriptions of their headache attack characteristics and burden of disease related to their headache disorders. The goal of the research is to develop accessible, evidence-based digital medical tools as low-effort applications for the correct diagnosis of headache disorders and estimation of burden of disease due to headache disorders.

NCT ID: NCT05376163 Not yet recruiting - Neck Pain Clinical Trials

Validity of Headache Disability Index

Start date: September 1, 2022
Phase:
Study type: Observational

The aim of our study is to investigate the Turkish validity and reliability of The Henry Ford Hospital Headache Disability Questionnaire (HDI), which has not been previously studied in a Turkish version for any headache type in patients with cervicogenic headache.

NCT ID: NCT05365880 Recruiting - Stroke Clinical Trials

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

Start date: March 23, 2022
Phase: Phase 2
Study type: Interventional

Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.

NCT ID: NCT05337930 Withdrawn - Clinical trials for Primary Headache Disorder

Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine

Start date: August 4, 2022
Phase: N/A
Study type: Interventional

This study aims to inform the continued development of a mobile app intended to support the treatment of CYP with migraine. After extensive public and patient involvement, Happyr Health has developed a mobile app that allows children and young people to track headache attacks and emotional wellbeing and to access coping techniques. With the use of gamification and storytelling elements, the app aims to engage children to be an active part in tracking and coping with their headaches. The outcomes of this study will inform future adaptations and development cycles of the Happyr Health app. 15 participants aged 10-16 will access the Happyr app for 8 weeks (= intervention). Primary outcomes of acceptability and implementation will be measured via surveys following the 8-week intervention in the app.

NCT ID: NCT05337033 Recruiting - Chronic Migraine Clinical Trials

Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

CAN-CHA
Start date: November 27, 2023
Phase: Phase 1
Study type: Interventional

Chronic headaches are a major cause of disability among adolescents. Cannabis products have supported the management of headaches in adults and may play a role in pediatric chronic pain. We propose a multisite, open-label, tolerability study conducted across three centers in Canada of Cannabidiol-enriched Cannabis Herbal Extract in adolescents (ages 14 to 17 years old) with chronic headaches. The study includes a one month baseline assessment, four months of escalating treatment doses and a weaning period. Our primary outcome is tolerability defined as the number and severity of reported adverse events.

NCT ID: NCT05334927 Not yet recruiting - Migraine Clinical Trials

China HeadAche DIsorders RegiStry

CHAIRS
Start date: August 29, 2022
Phase:
Study type: Observational [Patient Registry]

It is planned to include 10000 patients. In the China HeadAche DIsorders RegiStry CHAIRS), patients aged over 12 years with primary headache and medication-overuse headache(MOH) were collected. The biomarkers, imaging features, cognition, genetic characteristics, ocial and demographic data, medical data, therapeutics used, and outcome of headache-related diseases were studied, and long-term follow-up was planned.

NCT ID: NCT05328635 Recruiting - Clinical trials for Post-Concussion Syndrome

Post-traumatic Headache Multidisciplinary Study

PTHMS
Start date: September 1, 2021
Phase:
Study type: Observational

The study will investigate the effect of pharmacological preventive treatment, education, physiotherapy and psychological counselling on the headache and associated symptoms in patients refered to the Danish Headache Center

NCT ID: NCT05326867 Completed - Analgesia Clinical Trials

Comparison of Infiltration of 2% Lidocaine With and Without Needle as Analgesia in Epidural Needle Insertion

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

One way to reduce pain during epidural needle insertion is infiltration of lidocaine using a needle. However, infiltration of lidocaine using the needle alone is a painful process. Free needle infiltration of lidocaine can be an alternative to reduce epidural needle insertion pain. The study of Gozdemir et al. found that 10% lidocaine infiltration without needle was less painful than 2% lidocaine infiltration with a 27G needle with no significant difference in analgesia effect during epidural needle insertion. This study aimed to compare infiltration of lidocaine with and without needle for epidural needle insertion in a double-blind study, using a Tuohy needle, Comfort-inTM injector, and wider surgical group as novelty from previous studies. This study was a double blind randomized controlled trial. Data collection was carried out consecutively on 84 subjects with 42 subjects in each group of lidocaine infiltration without needles and lidocaine infiltration with 23G needles. The effectiveness of analgesia was assessed from three variables like pain with a Numeric Pain Rating Scale (NPRS) of 0 to 10 during lidocaine infiltration, pain with NPRS during epidural needle insertion, and patient movement during epidural needle insertion.

NCT ID: NCT05326802 Completed - Clinical trials for Cardiovascular Diseases

The U.S. Embryologist Fatigue Study

FUSE
Start date: April 7, 2022
Phase:
Study type: Observational

The purpose of the study is to determine physical and mental health issues of U.S. embryologists related to their occupational characteristics, and how workplace fatigue and burnout may affect their quality of life, cynicism, interactions with patients, attention to detail, and lead to human error, the cause of the most severe IVF incidents that often make headlines and result in costly litigation. It will also correlate how the current manual workflows contribute to these health issues, and what measures can be taken to improve both working conditions and embryologists' health, and, therefore, improve patient care.